Role of IL-12 in peripheral blood mononuclear cell responses to fungi in persons with and without HIV infection

Journal of Immunology

Volumn 156, Issue 11, 1996, Pages 4492-4497

  Harrison, Thomas S ^a   Levitz, Stuart M ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; GENE EXPRESSION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MYCOSIS; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS CARINII; PNEUMOCYSTOSIS; PRIORITY JOURNAL; SERODIAGNOSIS;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; BASE SEQUENCE; CANDIDA ALBICANS; CRYPTOCOCCUS NEOFORMANS; DNA PRIMERS; FUNGI; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; IMMUNOTHERAPY; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; MYCOSES; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS;

EID: 0030010968     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Powderly, W. G. 1994. Fungi. In Textbook of AIDS Medicine. S. M. Broder, T. C. Merigan, Jr., and D. Bolognesi, eds. Williams & Wilkins, Baltimore, p. 345.
2. Clerici, M., F. T. Hakim, D. J. Venzon, S. Blatt, C. W. Hendrix, T. A. Wynn, and G. M. Shearer. 1993. Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91:759.
3. Maggi, E., M. Mazzetti, A. Ravina, F. Annunziato, M. de Carli, M. P. Piccinni, R. Manetti, M. Carbonari, A. M. Pesce, G. del Prete, and S. Romagnani. 1994. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 265:244.
4. Trinchieri, G. 1994. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 84:4008.
5. Hendrzak, J. A., and M. J. Brunda. 1995. Biology of disease: interleukin-12, biologic activity, therapeutic utility, and role in disease. Lab. Invest. 72:619.
6. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzonite, S. F. Wolf, and G. Trinchieri. 1992. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176:1387.
7. Chehimi, J., S. E. Starr, I. Frank, A. D'Andrea, X. Ma, R. R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361.
8. Clerici, M., D. R. Lucey, J. A. Berzofsky, L. A. Pinto, T. A. Wynn, S. P. Blatt, M. J. Dolan, C. W. Hendrix, S. F. Wolf, and G. M. Shearer. 1993. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262:1721.
9. Newman, G. W., J. R. Guarnaccia, E. A. Vance III, J. Y. Wu, H. G. Remold, and P. H. Kazanjian, Jr. 1994. Interleukin-12 enhances antigen-specific proliferation of peripheral blood mononuclear cells from HIV-positive and negative donors in response to Mycobacterium avium. AIDS 8:1413.
10. Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, S. Wolf, P. Puccetti, and F. Bistoni. 1994. Interleukin-12 but not interferon-gamma production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur. J. Immunol. 24:909.
11. Romani, L., A. Mencacci, L. Tonnetti, R. Spaccapelo, E. Cenci, P. Puccetti, S. F. Wolf, and F. Bistoni. 1994. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol. 153:5167.
12. Clemons, K. V., E. Brummer, and D. A. Stevens. 1994. Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob. Agents Chemother. 38:460.
13. Levitz, S. M., A. Tabuni, H. Kornfeld, C. C. Reardon, and D. T. Golenbock. 1994. Production of tumor necrosis factor-alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect. Immun. 62:1975.
14. Chaisson, R. E., and P. A. Volberding. 1995. Clinical manifestations of HIV infection. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, Vol. 1, 4th Ed. G. L. Mandell, J. E. Bennett, and R. Dolin, eds. Churchill Livingstone, New York, p. 1217.
15. Treseler, C. B., R. T. Maziarz, and S. M. Levitz. 1992. Biological activity of interleukin-2 bound to Candida albicans. Infect. Immun. 60:183.
16. Levitz, S. M., A. Tabuni, S. Nong, and D. T. Golenbock. 1995. Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, C. albicans, and lipopolysaccharide. Infect. Immun. In press.
17. Edman, J. C., J. A. Kovacs, H. Masur, D. V. Santi, H. J. Elwood, and M. L. Sogin. 1988. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 334:519.
18. Ypma-Wong, M. F., W. A. Fonzi, and P. S. Sypherd. 1992. Fungus-specific translation elongation factor 3 gene present in Pneumocystis carinii. Infect. Immun. 60:4140.
19. Wolf, S. F., D. Sieburth, and J. Sypek. 1994. Interleukin 12: a key modulator of immune function. Stem Cells 12:154.
20. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827.
21. + T lymphocytes, and NK cells. J. Immunol. 149:3495.
22. Flesch, I. E., J. H. Hess, S, Huang, M. Aguet, J. Rothe, H. Bluethmann, and S. H. Kaufmann. 1995. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon gamma and tumor necrosis factor alpha. J. Exp. Med. 181:1615.
23. Lane, H. C., H. Masur, L. C. Edgar, G. Whalen, A. H. Rook, and A. S. Fauci. 1983. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309:453.
24. Hayes, M. P., J. H. Wang, and M. A. Norcross. 1995. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes. Blood 86:646.
25. Kubin, M., J. M. Chow, and G. Trinchieri. 1994. Differential regulation of interleukin-12 (IL-12), tumor necrosis factor alpha, and IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 83:1847.
26. Murray, H. W., B. Y. Rubin, H. Masur, and R. B. Roberts. 1984. Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N. Engl. J. Med. 310:883.
27. Zhang, M., J. Gong, D. V. Iyer, B. E. Jones, R. L. Modlin, and P. F. Barnes. 1994. T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J. Clin. Invest. 94:2435.
28. Gazzinelli, R. T., S. Bala, R. Stevens, M. Baseler, L. Wahl, J. Kovacs, and A. Sher. 1995. HIV infection suppresses type 1 lymphokine and IL-12 responses to Tomplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines. J. Immunol. 155:1565.
29. Miller, G. P. G., and J. Puck. 1984. In vitro human lymphocyte responses to Cryptococcus neoformans: evidence for primary and secondary responses in normals and infected subjects. J. Immunol. 133:166.
30. Hoy, J. F., D. E. Lewis, and G. G. Miller. 1988. Functional versus phenotypic analysis of T cells in subjects seropositive for the human immunodeficiency virus: a prospective study of in vitro responses to Cryptococcus neoformans. J. Infect. Dis. 158:1071.
31. Hofmann, B., K. D. Jakobsen, N. Odum, E. Dickmeiss, P. Platz, L. P. Ryder, C. Pedersen, L. Mathiesen, I. B. Bygbjerg, V. Faber, and A. Svejgaard. 1989. HIV-induced immunodeficiency: relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway. J. Immunol. 142:1874.
32. Quinti, I., C. Palma, E. C. Guerra, M. J. Gomez, I. Mezzaroma, F. Aiuti, and A. Cassone. 1991. Proliferative and cytotoxic responses to mannoproteins of Candida albicans by peripheral blood lymphocytes of HIV-infected subjects. Clin. Exp. Immunol. 85:485.
33. Hagler, D. N., G. S. Deepe, C. L. Pogue, and P. D. Walzer. 1988. Blastogenic responses to Pneumocystis carinii among patients with human immunodeficiency (HIV) infection. Clin. Exp. Immunol. 74:7.
34. Forte, M., G. Maartens, F. Campbell, C. Stubberfield, M. Shahmanesh, D. Kumararatne, and H. Gaston. 1992. T-lymphocyte responses to Pneumocystis carinii in healthy and HIV-positive individuals. J. Acquired Immune Defic. Syndr. 5:409.
35. Gazzinelli, R. T., S. Hieny, T. A. Wynn, S. Wolf, and A. Sher. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115.
36. Chehimi, J., S. E. Starr, I. Frank, M. Rengaraju, S. J. Jackson, C. Llanes, M. Kobayashi, B. Perussia, D. Young, E. Nickbarg, S. F. Wolf, and G. Trinchieri. 1992. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J. Exp. Med. 175:789.
37. Horn, C. A., and R. G. Washburn. 1995. Anticryptococcal activity of NK cell-enriched peripheral blood lymphocytes from human immunodeficiency virus-infected subjects: responses to interleukin-2, interferon-gamma, and interleukin-12. J. Infect. Dis. 172:1023.